Histiocytosis, Langerhans-Cell [clinicaltrials_resource:47ad888bbf2bccba015f8bcc8e24082e]
condition [clinicaltrials_vocabulary:condition]
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [clinicaltrials:NCT00002947]Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00008164]clinicaltrials:NCT00008216Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL [clinicaltrials:NCT00048373]Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases [clinicaltrials:NCT00084695]clinicaltrials:NCT00145626clinicaltrials:NCT00176826Stem Cell Transplant for Immunologic or Histiocytic Disorders [clinicaltrials:NCT00176865]Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis [clinicaltrials:NCT00276757]Cardiovascular Risk Factors and LCH in Adults [clinicaltrials:NCT00483925]H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis [clinicaltrials:NCT00488605]clinicaltrials:NCT00588536clinicaltrials:NCT00618540clinicaltrials:NCT00890747clinicaltrials:NCT01049854Unrelated Donor Transplant for Malignant and Non-Malignant Disorders [clinicaltrials:NCT01050439]Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis [clinicaltrials:NCT01225601]Ceftriaxone in Non-neutropenic Fever [clinicaltrials:NCT01225718]clinicaltrials:NCT01273766A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis [clinicaltrials:NCT01395004]clinicaltrials:NCT01473797Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function [clinicaltrials:NCT01651507]Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies [clinicaltrials:NCT01652092]Clofarabine for Langerhans in Pedi [clinicaltrials:NCT01796405]CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease [clinicaltrials:NCT01966367]Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. [clinicaltrials:NCT02012231]clinicaltrials:NCT02205762clinicaltrials:NCT02389400clinicaltrials:NCT02425904
condition browse [clinicaltrials_vocabulary:condition-browse]
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [clinicaltrials:NCT00002947]Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00008164]clinicaltrials:NCT00008216Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL [clinicaltrials:NCT00048373]Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases [clinicaltrials:NCT00084695]clinicaltrials:NCT00145626clinicaltrials:NCT00176826Stem Cell Transplant for Immunologic or Histiocytic Disorders [clinicaltrials:NCT00176865]Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis [clinicaltrials:NCT00276757]Cardiovascular Risk Factors and LCH in Adults [clinicaltrials:NCT00483925]H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis [clinicaltrials:NCT00488605]clinicaltrials:NCT00588536clinicaltrials:NCT00618540clinicaltrials:NCT00890747clinicaltrials:NCT01049854Unrelated Donor Transplant for Malignant and Non-Malignant Disorders [clinicaltrials:NCT01050439]Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis [clinicaltrials:NCT01225601]Ceftriaxone in Non-neutropenic Fever [clinicaltrials:NCT01225718]clinicaltrials:NCT01273766A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis [clinicaltrials:NCT01395004]clinicaltrials:NCT01473797Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function [clinicaltrials:NCT01651507]Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies [clinicaltrials:NCT01652092]Clofarabine for Langerhans in Pedi [clinicaltrials:NCT01796405]CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease [clinicaltrials:NCT01966367]Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. [clinicaltrials:NCT02012231]clinicaltrials:NCT02205762clinicaltrials:NCT02389400clinicaltrials:NCT02425904
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Histiocytosis, Langerhans-Cell [clinicaltrials_resource:47ad888bbf2bccba015f8bcc8e24082e]
Bio2RDF identifier
47ad888bbf2bccba015f8bcc8e24082e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:47ad888bbf2bccba015f8bcc8e24082e
identifier
clinicaltrials_resource:47ad888bbf2bccba015f8bcc8e24082e
title
Histiocytosis, Langerhans-Cell
@en
type
label
Histiocytosis, Langerhans-Cell [clinicaltrials_resource:47ad888bbf2bccba015f8bcc8e24082e]
@en
Histiocytosis, Langerhans-Cell